河古点针治疗穿过管部位的管疼痛:随机对照试验
Gülay Turgay1, Banu Çevik2, Yasemin Eskigülek2
1Vocational School of Health Services, Başkent University, Ankara, Türkiye.
概括
黑古 (LI4) 点针显著减少了血液透析患者的针插入疼痛与动脉静脉 (AVFs). 这种非药理学方法在各种AVF地点提供了更好的舒适性.
科学领域:
- 科和疼痛管理
- 补充和替代医学 补充和替代医学
背景情况:
- 与管相关的疼痛是动脉静脉囊 (AVF) 的血液透析患者的一个重要问题.
- 寻求非药理学策略,以提高患者在透析过程中的舒适性.
- 黑古 (LI4) 点针是治疗疼痛的一种潜在干预措施.
研究的目的:
- 评估Hegu (LI4) 点针在缓解管相关疼痛方面的有效性.
- 评估针对位于不同解剖区域的AVF的影响 (前,布雷西亚-西米诺,吸烟盒).
主要方法:
- 一项随机对照研究涉及131名患有AVF的血液透析患者.
- 干预组接受了Hegu针3分钟的压力治疗,然后在三次会议中进行管.
- 疼痛强度是用数值评分尺度测量;数据是用混合设计ANOVA分析的.
主要成果:
- 在干预组中,在所有管部位观察到疼痛得分的显著下降.
- 布雷西亚-奇米诺地区显示出最明显的疼痛减轻 (2.18到0.81).
- 对照组的疼痛得分保持稳定或增加,而较大的效果大小有利于针.
结论:
- 黑古点针疗法有效地减少了AVF的血液透析患者的管疼痛.
- 镇痛作用在布雷西亚-西米诺管区域最为显著.
- 针是一种可行的非药物选择,用于控制透析相关的疼痛.
相关概念视频
Conserved Binding Sites
5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
Conserved Binding Sites
1.9K
1.9K
Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Trial and Error and Algorithm
403
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
403


